Medications
FDA approves Darzalex Faspro for treating multiple myeloma
The U.S. Food and Drug Administration has approved Johnson & Johnson's Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for induction and consolidation ...
Aug 8, 2024
0
14